Dibose Tablet (Voglibose)

Adult dose

The usual adult dose is 0.2mg of voglibose orally 3 times daily immediately before each meal. If the effect is inadequate, the dose may be increased to 0.3mg per dose while carefully monitoring the patient's progress.

This medication should not be used in patients with severe ketosis or diabetic coma. It is also advisable not to administer this medication to patients with severe infections or during the perioperative period, as well as to severely traumatized patients. Patients who are allergic to any components of this medication should not use it. Additionally, since this medication contains lactose, it should not be given to patients with genetic issues such as galactose intolerance, lactase deficiency, and glucose-galactose malabsorption. Caution is required when using this medication in patients with chronic gastrointestinal diseases who have issues with digestion and absorption, and those with excessive intestinal gas as symptoms may worsen. Caution is also advised for patients with severely impaired liver or kidney function, as metabolic changes may affect blood sugar control. For elderly patients, it is safer to start at a low dose and monitor their condition. When used with other hypoglycemic agents, careful administration is necessary due to the risk of hypoglycemia. Hypoglycemic symptoms may appear when using this medication, and it is important to administer glucose, not sugar, when hypoglycemia is suspected. Abdominal bloating or increased flatulence may occur, and symptoms like intestinal obstruction may also appear, so these should be carefully monitored. Liver function disorders may occur, requiring regular testing of liver enzyme levels and symptom monitoring. In particular, patients with severe liver cirrhosis need to pay close attention to bowel movements, as constipation may worsen hyperammonemia. Gastrointestinal symptoms such as diarrhea, abdominal pain, nausea, and vomiting may occur, and rare allergic reactions like rash or itching may also be seen. Neurological symptoms such as headaches, dizziness, drowsiness have also been reported. This medication is only for patients diagnosed with diabetes and should be used cautiously in patients with similar symptoms that are not diabetes. Blood sugar control should be regularly checked, and if there is insufficient effect after 2-3 months of use, other treatment options should be considered. Women who are pregnant or may become pregnant should only use this medication if absolutely necessary, as its safety has not been established. Nursing mothers are advised to avoid using this medication and should discontinue breastfeeding if use is unavoidable. Safety in children has not been established, so it is advisable not to use it in pediatric patients. Elderly patients should start at a low dose due to decreased physiological function and closely monitor blood sugar and side effects.

• Hypoglycemia
• abdominal distension
• increased flatulence
• intestinal obstruction
• acute hepatitis
• elevated AST
• elevated ALT
• severe liver dysfunction
• jaundice
• worsening hyperammonemia

This medication is susceptible to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature of 1 to 30 degrees Celsius at room temperature. This way, the effectiveness and safety of the medication can be preserved for a long time.

Appearance

White to yellowish-white circular tablets

Package unit

30 tablets/bottle, 300 tablets/bottle